全文获取类型
收费全文 | 95篇 |
免费 | 5篇 |
专业分类
临床医学 | 16篇 |
内科学 | 15篇 |
综合类 | 28篇 |
预防医学 | 6篇 |
药学 | 7篇 |
中国医学 | 28篇 |
出版年
2023年 | 2篇 |
2022年 | 2篇 |
2021年 | 2篇 |
2020年 | 2篇 |
2019年 | 1篇 |
2018年 | 4篇 |
2017年 | 1篇 |
2015年 | 1篇 |
2014年 | 8篇 |
2013年 | 2篇 |
2012年 | 7篇 |
2011年 | 4篇 |
2010年 | 2篇 |
2009年 | 7篇 |
2008年 | 1篇 |
2007年 | 8篇 |
2006年 | 5篇 |
2005年 | 3篇 |
2004年 | 2篇 |
2003年 | 2篇 |
2002年 | 3篇 |
2001年 | 5篇 |
2000年 | 7篇 |
1999年 | 2篇 |
1997年 | 7篇 |
1996年 | 6篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1986年 | 1篇 |
1984年 | 1篇 |
排序方式: 共有100条查询结果,搜索用时 171 毫秒
61.
Objective To compare the efficacy of high and low dose atorvastatin on preventing contrast induced nephropathy (CIN) in patients underwent diagnostic and therapeutic coronary intervention. Methods All patients received atorvastatin 10 mg/d on the basis of hydrated therapy (n =100) and high dose group received additional atorvastatin 80 nag at 12 to 24 hours before procedure (n =50). Scr, Ccr, blood β2-M, urine NAG/Cr, and urine osmolality before and after the procedure were compared between the groups. Results Baseline demographic characteristics and nephropathy risk factors were similar between groups. Cer was significantly reduced while blood β2-M and uric NAG/Cr were significantly increased in low dose group (all P < 0.05) . Blood β2-M in the high dose group was significantly lower than that in the low dose group at day 1 [(2.35±0.52) mg/L vs. (2.67±0.64) mg/L, P =0.008], day 3[(2.49±0.55)mg/L vs. (2.80±0.64) mg/L,P =0.011] and day 5[(2.29±0.53) mg/L vs. (2.56±0.66) nag/L, P = 0.026] post-procedure respectively; urine NAG/Cr in the high dose group was also significantly lower than that in the low dose group at day 1 [(1.19±0.30) U/mmol vs. (1.46±0.34) U/mmol, P < 0.001], day 3 [(1.30±0.30) U/mmol vs. (1.59±0.33) U/mmol, P < 0.001], and day 5 [(1.10±0.30) U/mmol vs. (1.34±0.35) U/mmol, P = 0.001] post-procedure respectively;Cer in the high dose group was significantly higher than that in the low dose group at day 1 [(73.69±20.99) mL/min vs. (65.19±18.72) mL/min,P =0.035], day 3[(64.04±15.82) ml/min vs. (56.79±14.50)ml/min,P =0.019] post-procedure respectively. Conclusion High dose atorvastatin use before angiography is superior than low dose atorvastatin on attenuating contrast induced renal dysfunction. 相似文献
62.
目的分析密闭式吸痰在新生儿机械通气中的应用及对患儿血气指标的影响。方法选取2016年2月-2017年2月在天津市中心妇产科医院NICU病房接受机械通气治疗的80例新生儿为研究对象,依据随机数表法分为研究组和对照组,每组各40例。对照组患儿采用开放式吸痰方式,研究组患儿采用密闭式吸痰方式。观察并对比治疗前、后两组患儿的动脉血气(PaO_2、PaCO_2)指标、并发症发生情况及痰液喷溅情况。结果治疗前,两组患者的动脉血气指标(PaO_2、PaCO_2)检测水平比较,差异无统计学意义(P0.05);吸痰治疗20 min后,两组患儿PaO_2水平升高,PaCO_2降低,差异有统计学意义(P0.05)。治疗后,研究组患儿并发症总发生率和痰液啧溅率低于对照组,差异有统计学意义(P0.05)。结论新生儿机械通气中采用密闭式吸痰方式,能彻底切断接触性传播及空气传播途径,可有效稳定患儿动脉血气指标,降低呼吸机相关性肺炎(VAP)等并发症的发生率,值得临床推广。 相似文献
63.
Objective To compare the efficacy of high and low dose atorvastatin on preventing contrast induced nephropathy (CIN) in patients underwent diagnostic and therapeutic coronary intervention. Methods All patients received atorvastatin 10 mg/d on the basis of hydrated therapy (n =100) and high dose group received additional atorvastatin 80 nag at 12 to 24 hours before procedure (n =50). Scr, Ccr, blood β2-M, urine NAG/Cr, and urine osmolality before and after the procedure were compared between the groups. Results Baseline demographic characteristics and nephropathy risk factors were similar between groups. Cer was significantly reduced while blood β2-M and uric NAG/Cr were significantly increased in low dose group (all P < 0.05) . Blood β2-M in the high dose group was significantly lower than that in the low dose group at day 1 [(2.35±0.52) mg/L vs. (2.67±0.64) mg/L, P =0.008], day 3[(2.49±0.55)mg/L vs. (2.80±0.64) mg/L,P =0.011] and day 5[(2.29±0.53) mg/L vs. (2.56±0.66) nag/L, P = 0.026] post-procedure respectively; urine NAG/Cr in the high dose group was also significantly lower than that in the low dose group at day 1 [(1.19±0.30) U/mmol vs. (1.46±0.34) U/mmol, P < 0.001], day 3 [(1.30±0.30) U/mmol vs. (1.59±0.33) U/mmol, P < 0.001], and day 5 [(1.10±0.30) U/mmol vs. (1.34±0.35) U/mmol, P = 0.001] post-procedure respectively;Cer in the high dose group was significantly higher than that in the low dose group at day 1 [(73.69±20.99) mL/min vs. (65.19±18.72) mL/min,P =0.035], day 3[(64.04±15.82) ml/min vs. (56.79±14.50)ml/min,P =0.019] post-procedure respectively. Conclusion High dose atorvastatin use before angiography is superior than low dose atorvastatin on attenuating contrast induced renal dysfunction. 相似文献
64.
65.
66.
Objective To compare the efficacy of high and low dose atorvastatin on preventing contrast induced nephropathy (CIN) in patients underwent diagnostic and therapeutic coronary intervention. Methods All patients received atorvastatin 10 mg/d on the basis of hydrated therapy (n =100) and high dose group received additional atorvastatin 80 nag at 12 to 24 hours before procedure (n =50). Scr, Ccr, blood β2-M, urine NAG/Cr, and urine osmolality before and after the procedure were compared between the groups. Results Baseline demographic characteristics and nephropathy risk factors were similar between groups. Cer was significantly reduced while blood β2-M and uric NAG/Cr were significantly increased in low dose group (all P < 0.05) . Blood β2-M in the high dose group was significantly lower than that in the low dose group at day 1 [(2.35±0.52) mg/L vs. (2.67±0.64) mg/L, P =0.008], day 3[(2.49±0.55)mg/L vs. (2.80±0.64) mg/L,P =0.011] and day 5[(2.29±0.53) mg/L vs. (2.56±0.66) nag/L, P = 0.026] post-procedure respectively; urine NAG/Cr in the high dose group was also significantly lower than that in the low dose group at day 1 [(1.19±0.30) U/mmol vs. (1.46±0.34) U/mmol, P < 0.001], day 3 [(1.30±0.30) U/mmol vs. (1.59±0.33) U/mmol, P < 0.001], and day 5 [(1.10±0.30) U/mmol vs. (1.34±0.35) U/mmol, P = 0.001] post-procedure respectively;Cer in the high dose group was significantly higher than that in the low dose group at day 1 [(73.69±20.99) mL/min vs. (65.19±18.72) mL/min,P =0.035], day 3[(64.04±15.82) ml/min vs. (56.79±14.50)ml/min,P =0.019] post-procedure respectively. Conclusion High dose atorvastatin use before angiography is superior than low dose atorvastatin on attenuating contrast induced renal dysfunction. 相似文献
67.
<正> 自1983年我们用自拟利湿定眩汤治疗痰湿中阻型耳眩晕效果满意,现总结报告如下。1 临床资料76例中,男31例,女45例。其中15~20岁者2例,21~30岁者13例,31~40岁者24例,41~50岁者32例,51~60岁者5例。病史最长者18年,最短者2年。 相似文献
68.
张学颖 《中华医学教育探索杂志》2011,10(5):616-619
目的通过分析《医学教育探索》载文、作者、引文统计情况,探索该刊的特点和规律,为今后的办刊提供参考依据。方法运用文献计量学的统计方法,以该刊2010年刊载的615篇论文为研究对象,从载文、作者、和引文3个方面进行统计分析,具体指标包括载文量、基金项目、栏目设置、合著情况、作者分布、引文量、引文类型、引文语种,并进行比较分析。结果2010年该刊载文615篇,共1728页,篇均页数2.18,篇密度0.36篇/页;以教学改革和临床教学为主要栏目,分别占载文量的19.51%、16.75%。作者总数2084人,无作者和独著论文87篇,合著论文528篇,合著率85.85%,合作度3.39人/篇。引文4331条,篇均引文数7.04条,引文率为99.51%。结论该刊信息量大、栏目丰富、重点突出,在全国影响力大,但是引文量稍低,且外文文献引用偏少。 相似文献
69.
舌咽神经痛临床较少见。自1979年9月至1982年4月,笔者采用非手术疗法治疗舌咽神经痛7例,现报告如下。一、发病情况本组男4例,女3例;年龄除1例为40岁外,余皆在50~60岁之间。其中右侧发病4例,左侧3例;发病至就诊时间最短3天, 相似文献
70.
临沂中医外科名医——汤坤标汤坤标(1937~),福建龙岩人,1963年毕业于上海中医学院医疗系本科。现任临沂市中医医院副院长、主任中医师,临沂市中医药学会名誉理事长,1995年4月被山东省卫生厅、人事厅确定为名老中医药专家学术经验继承工作指导老师。从... 相似文献